from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1389/gmk

LFCtreatmentdescriptionclass of inhibitor

1.737

Amikacinug/mL Amikacintranslation

1.586

Cap5-10ug/mL Capreomycintranslation

2.659

Rox10-50 ug/mL Roxithromycintranslation

0.919

SM2-5 ug/mL Streptomycintranslation

2.095

Tet5-10 ug/mL Tetracyclinetranslation

-0.457

Rif0.2-5ug/mL Rifampicintranscription

-1.930

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.558

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.249

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.037

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.161

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.023

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.342

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.396

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.758

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.351

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.281

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.019

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.484

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.398

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.290

KCN5-20 ug/mL Potassium cyaniderespiration

-0.409

NaN30.2-2 mM Sodium aziderespiration

-0.454

Nigericin50 uM Nigericinrespiration

-0.490

TRC10-150 ug/mL Triclosanrespiration

0.275

TRZ10-25 ug/mL Thioridazinerespiration

2.833

Valinomycin0.5-10 uM Valinomycinrespiration

-0.032

ZnSO42 mM ZnSO4respiration

-0.317

menadione6-10 ug/mL Menadionerespiration

-0.120

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.524

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.531

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.356

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.152

NRP_1Non-replicating persistence stage 1dosRassociated

-0.187

Amp0.2mg/mL AmpicillincellWall

-0.224

Cephalexin20-100 ug/mL CephalexincellWall

0.052

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.094

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.225

EMB10-20 ug/mL EthambutolcellWall

-0.179

Eta12-40 ug/mL EthionamidecellWall

-0.265

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.129

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.161

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.089

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.160

BZA0.12 mg/mL BenzamidearomaticAmides

0.862

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.377

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.361

H2O24 mM hydrogen peroxideDNAdamaging

1.224

Levo10 ug/mL LevofloxacinDNAdamaging

-0.572

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.706

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.375

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.445

UVUV-irradiationDNAdamaging

-0.475

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.929

Antimycin12.5-50 ug/mL Antimycin A?

-0.594

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.332

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.567

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.425

PA8240.2-2 ug/mL PA-824?

0.913

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.145

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.430

Verapamil50 uM Verapamil?

-0.484

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.822

methoxatin10-20 ug/mL Methoxatin?